News

BioMAdvanced Diagnostics received €900k in funding from Bpifrance

9 February 2023

🧪 The “Aide au Développement Deeptech (ADD)” Grant is reserved for startups which develop highly technological innovations. So for BioMAdvanced Diagnostics, it is not only a great financial help but also a key recognition of the significance of its innovations.

The funding will help the startup to:

  • go through the 2nd stage of development for its Kidney rejection test (analytical validation),
  • get through a 1st clinical study
  • get another one started.

Find out more about BioMAdvanced Diagnostics: biomadvanced-diagnostics.com